Charles River Laboratories International, Inc. Forecast, price target & analysts
Charles River Laboratories International, Inc. Target price 2026 - Analyst rating & recommendation
Charles River Laboratories International, Inc. Classifications & Recommendation
Charles River Laboratories International, Inc. Price Target
| Target Price | $327.42 |
| Price | $302.00 |
| Potential |
8.42%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Charles River Laboratories International, Inc. 2027 .
The average Charles River Laboratories International, Inc. target price is $327.42.
This is
8.42%
register free of charge
$374.85
24.12%
register free of charge
$147.27
51.24%
register free of charge
|
|
| A rating was issued by 23 analysts: 17 Analysts recommend Charles River Laboratories International, Inc. to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Charles River Laboratories International, Inc. stock has an average upside potential 2027 of
8.42%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.02 | 3.95 |
| 0.85% | 1.63% | |
| EBITDA Margin | 16.97% | 25.49% |
| 0.32% | 50.25% | |
| Net Margin | -3.59% | 13.85% |
| 1,513.44% | 485.29% |
18 Analysts have issued a sales forecast Charles River Laboratories International, Inc. 2026 . The average Charles River Laboratories International, Inc. sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Charles River Laboratories International, Inc. EBITDA forecast 2026. The average Charles River Laboratories International, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 Charles River Laboratories International, Inc. Analysts have issued a net profit forecast 2026. The average Charles River Laboratories International, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.91 | 11.46 |
| 1,555.00% | 493.81% | |
| P/E | 26.36 | |
| EV/Sales | 4.27 |
20 Analysts have issued a Charles River Laboratories International, Inc. forecast for earnings per share. The average Charles River Laboratories International, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Charles River Laboratories International, Inc....
Current Charles River Laboratories International, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Sep 30 2026 |
| Jefferies |
Locked
➜
Locked
|
Locked | Sep 28 2026 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Sep 25 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Sep 25 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Sep 25 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Sep 25 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Sep 25 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Sep 30 2026 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Sep 28 2026 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Sep 25 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Sep 25 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Sep 25 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Sep 25 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Sep 25 2026 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
